Genetics of Ataxia
Many forms of ataxia are due to inheritance of a gene that carries a mutation. A gene is the cell's instructions for making a specific protein. In some cases, the mutation causes the protein not to be made at all, or to be useless (a "loss-of-function" mutation). In other cases, the mutation causes the protein to take on some new function which is bad for the cell (a "toxic-gain-of-function" mutation).
The chart shows the known genetic forms of ataxia, the name of the mutated gene and its protein product, and important clinical features. It also indicates the pattern of inheritance (see "Inheritance Patterns" on the next page), where the gene is located on the chromosomes (locus), the type of mutation, and whether genetic testing is available.
The number of recognized genetic ataxias has grown considerably due to advances in gene discovery methods. Most forms are quite rare.
| designation |
gene/gene product |
mean age at onset |
prominent features |
inheritance |
locus |
mutation |
genetic testing available |
comments |
| SCA1 |
ATXN1/ataxin-1 |
4th decade |
Bulbar, corticospinal, extrapyramidal signs |
AD |
6p23 |
CAG repeat |
yes |
6% of all AD cerebellar ataxia |
| SCA2 |
ATXN2/ataxin-2 |
4th decade |
slow saccades, neuropathy, dementia |
AD |
12q24 |
CAG repeat |
yes |
13% of all AD cerebellar ataxia |
| SCA3 Machado-Joseph disease |
ATXN3/ataxin-3; MJD protein 1 |
4th decade |
bulging eyes, facial fasciculations |
|
14q24.3-q31 |
CAG repeat |
yes |
23% of all AD cerebellar ataxia |
| SCA4 |
Q9H7K4/puratrophin-1 |
|
sensory neuropathy |
|
16q22.1 |
|
yes |
|
| SCA5 |
SPTBN2/spectrin beta chain, brain 2 |
4th decade |
|
|
11q13 |
|
yes |
|
| SCA6 |
CACNA1A/voltage-dependent P/Q-type calcium channel alpha-1A subunit |
6th decade |
|
|
19p13 |
CAG repeat |
yes |
|
| SCA7 |
ATXN7/ataxin-7 |
4th decade |
|
|
3p21.1-p12 |
CAG repeat |
yes |
|
| SCA8 |
KLHL1AS |
5th decade |
|
|
13q21 |
|
yes |
|
| SCA9 |
|
|
|
|
|
|
|
|
| SCA10 |
ATXN10/ataxin-10; E46L |
4th decade |
isolated ataxia |
|
22q13 |
|
yes |
|
| SCA11 |
|
3rd decade |
|
|
15q14-q21.3 |
|
|
|
| SCA12 |
PPP2R2B/brain-specific regulatory subunit of protein phosphatase 2A |
4th decade |
|
|
5q31-q33 |
|
yes |
|
| SCA13 |
|
Childhood |
|
|
19q13.3-q13.4 |
|
|
|
| SCA14 |
PRKCG/protein kinase C, gamma subtype |
3rd decade |
|
|
19q13.4 |
|
yes |
|
| SCA15 |
|
3rd decade |
|
|
3p26.1-p25.3 |
|
|
|
| SCA16 |
|
5th decade |
|
|
8q22.1-q24.1 |
|
|
|
| SCA17 |
TBP/TATA-box binding protein |
4th decade |
|
|
6q27 |
|
yes |
|
| SCA18 |
|
2nd decade |
|
|
7q22-q32 |
|
|
|
| SCA19 |
|
4th decade |
|
|
1p21-q21 |
|
|
|
| SCA20 |
|
5th decade |
|
|
11p13-q11 |
|
|
|
| SCA21 |
|
2nd decade |
|
|
7p21.3-p15.1 |
|
|
|
| SCA22 |
|
|
|
|
1p21-q21 |
|
|
|
| SCA23 |
|
|
|
|
20p13-p12.3 |
|
|
|
| SCA24 |
|
|
|
|
|
|
|
|
| SCA25 |
|
|
|
|
2p21-p13 |
|
|
|
| SCA26 |
|
|
|
|
19p13.3 |
|
|
|
| SCA27 |
FGF14/fibroblast growth factor 14 |
2nd decade |
|
|
13q34 |
|
yes |
|
| SCA28 |
|
|
|
|
18p11.22-q11.2 |
|
|
|
| Friedreich's ataxia |
frataxin |
mainly childhood, but 25% adult |
Areflexia, pes cavus, cardiomyopathy |
AR |
|
GAA repeat |
|
|
| DRPLA |
DRPLA/atrophin1-related protein |
4th decade |
Chorea, myoclonus, seizures, dementia |
|
12p13.31 |
CAG repeat |
yes |
|
| EA1 |
KCNA1/potassium voltage-gated channel component |
|
episodic ataxia, myokymia |
|
12p13 |
|
yes |
|
| EA2 |
CACNA1A/voltage-dependent P/Q-type calcium channel alpha-1A subunit |
|
episodic ataxia |
|
19p13 |
|
|
|
| FXTAS |
FMR-1 |
|
tremor, ataxia |
X-linked |
Xq27.3 |
CGG repeat |
|
usually male relatives of boys with fragile X syndrome |
SCA=spinocerebellar ataxia; DRPLA=dentatorubral pallidoluysian atrophy; EA=episodic ataxia; FXTAS=fragile X-associated tremor ataxia syndrome; AD=autosomal dominant; AR=autosomal recessive
Adapted from:
Brusse E, Maat-Kievet JA, van Swieten JC. Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 2007;71:12-14
and
Bower, JH. Familial Adult-Onset Spinocerebellar Degenerations, in Adler CH, Ahlskog JE, eds. Parkinson's Disease and Movement Disorders: Diagnosis and Treatment for the Practicing Physician. Totowa, NJ: Humana Press, 2007. pp243-252